Abstract
Penile cancer is an uncommon disease with minimal level I evidence to guide therapy. The National Comprehensive Cancer Network (NCCN) guidelines advocate a lymph node dissection (LND) or radiotherapy with consideration of perioperative chemotherapy for all patients with lymph node-positive (LN+) penile cancer without metastasis. To determine temporal trends in use of chemotherapy for patients with LN+ penile cancer without metastasis and to evaluate outcomes between those who did or did not receive LND, chemotherapy, and radiotherapy. The US National Cancer Database (NCDB) was queried for all 1123 patients with LN+, squamous cell carcinoma of the penis without metastasis from January 1, 2004, through December 31, 2014. Temporal trends were assessed using Cochran-Armitage tests. Multivariable logistic models were used to examine the association between treatments, clinicopathologic variables, and receipt of chemotherapy. Kaplan-Meier analyses with log-rank tests and multivariable Cox regressions were used to analyze overall survival. Data were analyzed between January 2017 and September 2017. Use of chemotherapy over time. Survival outcomes by receipt or nonreceipt of LND, radiotherapy, and chemotherapy. Of 1123 patients identif...Continue Reading
Citations
Nov 1, 2018·World Journal of Urology·Luca CindoloLuigi Schips
Sep 20, 2018·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·Michele MarchioniLuca Cindolo
Feb 8, 2019·Current Opinion in Urology·Juan ChipolliniPhilippe E Spiess
Feb 14, 2019·International Urology and Nephrology·Weipu MaoJiang Geng
May 15, 2019·Current Opinion in Supportive and Palliative Care·Ahmet Murat AydinPhilippe E Spiess
Jul 30, 2019·BJU International·Juan ChipolliniPhillippe E Spiess
Jul 12, 2019·World Journal of Urology·Joren VanthoorUNKNOWN and in collaboration with the European Reference Network for rare urogenital diseases and complex conditions (eUROGEN)
Jan 24, 2020·Current Opinion in Urology·Irene ReschShahrokh F Shariat
Jan 9, 2020·Current Opinion in Urology·Marco BandiniAndrea Necchi
Apr 18, 2020·Future Oncology·Hari MenonVivek Verma
Aug 6, 2020·Journal of Palliative Care·Facundo M DavaroZachary A Hamilton
Jul 15, 2020·BJU International·Marco BandiniAndrea Necchi
May 13, 2020·Cancer Causes & Control : CCC·Meifang ZhangLanjing Zhang
Apr 21, 2020·International Journal of Urology : Official Journal of the Japanese Urological Association·Ken TanakaHiroyuki Nishiyama
Jul 4, 2020·Andrology·Wei LiuXinghuan Wang
Aug 3, 2020·Current Opinion in Urology·Fahad QuhalShahrokh F Shariat
Dec 20, 2018·Annals of Surgical Oncology·Yao ZhuDing-Wei Ye
Oct 9, 2020·Acta Oncologica·Emma UlvskogJohan Ahlgren
Jan 10, 2021·Current Urology Reports·George Coba, Trushar Patel
Sep 19, 2020·European Urology Oncology·Marco BandiniAndrea Necchi
Feb 13, 2021·Nature Reviews. Disease Primers·Anita ThomasMaarten Albersen
Dec 15, 2020·Mayo Clinic Proceedings·Jad ChahoudPhilippe E Spiess
Feb 27, 2021·International Immunopharmacology·Ahmet Murat AydinShari Pilon-Thomas
Apr 7, 2021·Annales de pathologie·Eva CompératBenjamin Pradere
Nov 18, 2020·European Urology Oncology·Marco BandiniAndrea Necchi
Nov 11, 2019·Clinical Oncology : a Journal of the Royal College of Radiologists·F A MistrettaP I Karakiewicz